Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
26.31
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST
SHA:600993 Market Cap
SHA:600993 has a market cap or net worth of 11.34 billion as of November 20, 2026. It is the 6,910th most valuable company in the world and the 1,224th biggest in China. Its market cap has decreased by 3.70% in one year.
Market Cap
11.34B
Enterprise Value
9.03B
Revenue
3.99B
Global Rank
Country Rank
#1,224 China
PE Ratio
18.96
ChartMarket Cap Chart
Since June 22, 2004, SHA:600993's market cap has increased from 1.07B to 11.34B, an increase of 955.41%. That is a compound annual growth rate of 11.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 11.34B | -6.04% |
| Dec 31, 2025 | 12.07B | 7.24% |
| Dec 31, 2024 | 11.25B | 7.98% |
| Dec 29, 2023 | 10.42B | 6.99% |
| Dec 30, 2022 | 9.74B | -21.42% |
| Dec 31, 2021 | 12.40B | 42.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.17B |
| Shenzhen Kangtai Biological Products | 12.09B |
| Shenyang Xingqi Pharmaceutical | 11.74B |
| Shenzhen Hepalink Pharmaceutical Group | 11.56B |
| Guobang Pharma | 11.47B |
| Harbin Pharmaceutical Group | 11.46B |
| Porton Pharma Solutions | 10.95B |
| ApicHope Pharmaceutical Group | 10.65B |